Casma Therapeutics is based in Boston. It has raised $162M in total funding. Latest round: Grant.
Casma Therapeutics is based in Boston. Casma Therapeutics has raised $162M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Grant announced in March 2026. The round record for Casma Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Third Rock Ventures, The Column Group, Mirae Asset, Eventide Funds, The Chernin Group, Amgen Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
Round data for Casma Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026